At a glance
ClinicalIndex Comparison RecordN/ACompleted· 54 enrolled
Drug / intervention
balafilcon A contact lens (PureVision) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Deposits on Contact Lenses Worn Extended Wear
In Brief
A clinical study evaluating balafilcon A contact lens (PureVision) and etafilcon A contact lens (Acuvue2) for Myopia. Completed, enrolled 54 participants across 1 site.
Detailed Summary
The purpose of this study was to measure lipid deposits on commercially marketed contact lenses when worn on an extended wear (overnight) basis for 7 days.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2008
First PostedJul 2008
Primary CompletionOct 2008
TodayJul 2026
First PostedJul 30, 2008
Enrollment StartMar 1, 2008
Primary CompletionOct 1, 2008
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 17.9 years ago
Interventions
balafilcon A contact lens (PureVision)device
Commercially marketed, silicone hydrogel contact lens
etafilcon A contact lens (Acuvue2)device
Commercially marketed, hydrogel contact lens